erythromycin has been researched along with imatinib mesylate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Barni, R; Brueggen, J; Cabrita, G; Cleris, L; Corneo, G; Cozens, R; D'Incalci, M; Formelli, F; Gambacorti-Passerini, C; Gianazza, E; le Coutre, P; Pioltelli, P; Pogliani, E; Rossi, F; Zucchetti, M | 1 |
| Aono, Y; Azuma, M; Inayama, M; Izumi, K; Kinoshita, K; Kishi, J; Makino, H; Nishioka, Y; Ogushi, F; Shono, M; Sone, S; Uehara, H | 1 |
4 other study(ies) available for erythromycin and imatinib mesylate
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571.
Topics: Animals; Antineoplastic Agents; Benzamides; Blotting, Western; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Erythromycin; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Nude; Orosomucoid; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Time Factors; Tumor Cells, Cultured | 2000 |
Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice.
Topics: Animals; Benzamides; Cells, Cultured; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fibroblasts; Imatinib Mesylate; Macrolides; Mice; Orosomucoid; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines | 2007 |